Takeda Pharmaceutical Company

Takeda Pharmaceutical Company

World Rank (Aug-2026)
461
Market Cap (Aug-2026)
56.506 Billion USD
Market Cap (Mar-08-2026)
56.915 Billion USD
World Rank (Jan-05-2024)
379
Market Cap (Jan-05-2024)
46.349 Billion USD
World Rank (Jul-30-2023)
369
Market Cap (Jul-30-2023)
47.619 Billion USD
World Rank (Jan-07-2022)
468
Market Cap (Jan-07-2022)
43.085 Billion USD
World Rank (Jan-01-2021)
275
Market Cap (Jan-01-2021)
56.921 Billion USD
Company Rank in Country in 2023
Rank in Japan in 2023 is 26
Headquarters Country
Japan
Nasdaq / NYSE Code
TAK
CEO
Christophe Weber
Chairman
Yasuchika Hasegawa
Founders
Chobei Takeda I
Employee Count
47,347
Employee Count as of Date
As on 2022
Headquarters City/State
Tokyo
World Region
Asia
World Subregion
Eastern Asia
Annual Revenue in USD
30,531 Million USD
Annual Operating Income in USD
3,147 Million USD
Annual Net Income in USD
-1,033 Million USD
Annual Results for Period Ending
For year ending March-2026
Total Assets in USD
105,108 Million USD
Total Liabilities in USD
54,757 Million USD
Total Equity in USD
50,351 Million USD
Balance Sheet for Period Ending
As of March-2026
Business Sector
Healthcare
Pharmaceutical
HealthCare Products
Company Website
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Wikipedia
Wikipedia
Yahoo
Yahoo @ NYSE
Company Profile

TAKEDA PHARMACEUTICAL COMPANY is Pharmaceutical Company with headquarters is in Japan.

Annual Results Summary

TAKEDA PHARMACEUTICAL COMPANY - Annual Results - Revenue and Net Income - in Million JPY:

Year Ending:Total RevenueOperating IncomeNet Income
Mar-20234,027,478490,506317,017
Mar-20223,569,006460,845230,059
Mar-20213,197,812509,269376,005
Mar-20203,291,188100,40844,241
Balance Sheet Summary

Total Assets as on Mar-2023 was 13,957,750 Million JPY.

Total Liabilities as on Mar-2023 was 7,603,079 Million JPY.

Total Equity as on Mar-2023 was 6,354,671 Million JPY.

Founded Year
1781
Stock Category
NIKKEI 225
Japan ADRs
Stock Exchange
Tokyo
Frankfurt
NYSE

Share